Welcome to LookChem.com Sign In|Join Free

CAS

  • or

25907-29-3

Post Buying Request

25907-29-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25907-29-3 Usage

Uses

4-Bromo-5-methyl-1H-pyrrole-2-carboxylate Ethyl Ester is used in preparation of Piperidinylazolylthiazolecarboxlic Acid derivatives for use in the treatment of bacterial infections.

Check Digit Verification of cas no

The CAS Registry Mumber 25907-29-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,9,0 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 25907-29:
(7*2)+(6*5)+(5*9)+(4*0)+(3*7)+(2*2)+(1*9)=123
123 % 10 = 3
So 25907-29-3 is a valid CAS Registry Number.

25907-29-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-bromo-5-methyl-1H-pyrrole-2-carboxylic acid ethyl ester

1.2 Other means of identification

Product number -
Other names ethyl 4-bromo-5-methyl-1H-pyrrole-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25907-29-3 SDS

25907-29-3Relevant articles and documents

NOVEL PYRROLE DERIVATIVES FOR THE TREATMENT OF CANCER

-

Page/Page column 38, (2014/10/15)

The invention provides a method for the treatment of cancer, which method comprises the general formula (I) wherein R1, R2, R3, R4 and W are as described herein.

2-(PIPERIDIN-1-YL)-4-AZOLYL-THIAZOLE-5-CARBOXYLIC ACID DERIVATIVES AGAINST BACTERIAL INFECTIONS

-

Page/Page column 71, (2010/07/02)

Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25907-29-3